UMIN ID: UMIN000040526
Registered date:01/08/2020
Long-term immunity after Yellow fever vaccination
Basic Information
Recruitment status | Recruiting |
---|---|
Health condition(s) or Problem(s) studied | Yellow fever |
Date of first enrollment | 2020/12/18 |
Target sample size | 50 |
Countries of recruitment | Japan |
Study type | Observational |
Intervention(s) |
Outcome(s)
Primary Outcome | seropositivity rate of neutralizing antibody titers against yellow fever virus |
---|---|
Secondary Outcome | geometric mean titer of neutralizing antibody titers against yellow fever virus |
Key inclusion & exclusion criteria
Age minimum | 20years-old |
---|---|
Age maximum | Not applicable |
Gender | Male and Female |
Include criteria | |
Exclude criteria | no restriction |
Related Information
Primary Sponsor | Tokyo Medical University Hospital Travellers' Medical Center |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | Ministry of Education, Culture, Sports, Science and Technology |
Secondary ID(s) |
Contact
public contact | |
Name | SHINJI FUKUSHIMA |
Address | 6-7-1 Nishishinjuku, Shinjuku, Tokyo, Japan 160-0023 |
Telephone | +81-3-5339-3726 |
fuku789@tokyo-med.ac.jp | |
Affiliation | Tokyo Medical University Hospital Travellers' Medical Center |
scientific contact | |
Name | SHINJI FUKUSHIMA |
Address | 6-7-1 Nishishinjuku, Shinjuku, Tokyo, Japan |
Telephone | +81-3-5339-3726 |
fuku789@tokyo-med.ac.jp | |
Affiliation | Tokyo Medical University Hospital Travellers' Medical Center |